Durham, United States
Pappas Capital invests exclusively in the life science sector. For 28 years we have been investing in and building innovative companies that are developing the next generation of life science products and technologies. We’ve invested in more than 85 companies across the United States and Canada, in fields that span the range of human disease. The 25 products our companies have brought to market – for treating such conditions as melanoma, ovarian cancer, and hemophilia, to name a few – have been used throughout the world to treat tens of thousands of patients and account for billions of dollars of revenue. Whether you’re looking for capital or have capital to invest, contact us and learn how we can put our expertise to work for you.
28
Total Investments
22
Portfolio Companies
-
Exits
2
Industries
General Information
Industries
Biotechnology, Pharmaceutical
Funding Stage
Series A +1
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Pappas Capital
Recent Investments (28)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series A | •••••• | Oct 2026 | |
| Series A | •••••• | Apr 2025 | |
| Series A | •••••• | Apr 2024 | |
| Venture Round | •••••• | Oct 2023 | |
| Venture Round | •••••• | Jun 2023 | |
•••• ••••
|
Series A | •••••• | Mar 2023 |
|
•••• ••••
|
Series A | •••••• | Feb 2023 |
|
•••• ••••
|
Series B | •••••• | Jun 2022 |
|
•••• ••••
|
Series A | •••••• | Apr 2022 |
|
•••• ••••
|
Series B | •••••• | Feb 2022 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
